The results of the antibacterial assay using the well diffusion, MIC, and MBC methods were obtained for the hydroalcoholic extract of
Allium atroviolaceum and 0.2% chlorhexidine against
Streptococcus sanguinis,
Streptococcus mitis,
Streptococcus mutans,
Streptococcus sanguinis, and
Streptococcus salivarius. To better understand the significance of these findings, a comparison with existing literature is necessary. The well diffusion method demonstrated the inhibitory effect of the hydroalcoholic extract of tassel onion on the growth of the tested streptococci. The diameter of the growth inhibition halo was observed, with the extract showing varying degrees of effectiveness against different strains. The results demonstrated in
Figure 1 indicates that the extract exhibited the highest inhibitory effect against
Streptococcus salivarius, with a diameter of approximately 17.00 ± 2.00 mm. In contrast, the lowest inhibitory effect was observed against
Streptococcus mutans, with a diameter of approximately 12.00 ± 1.00 mm. Chlorhexidine, the positive control, displayed inhibition halos ranging from 19.00 ± 0.50 to 22.00 ± 1.00 mm, demonstrating its potent antimicrobial activity against the tested streptococci. In examining the well diffusion results, varying inhibitory effectiveness against different streptococcal strains suggests a nuanced interaction between the extract and specific bacterial species. Notably, the extract's highest inhibitory effect against
Streptococcus salivariusaligns with previous research on
Allium species, hinting at strain-specific responses.
In the MIC and MBC analysis, the hydroalcoholic extract of
Allium atroviolaceum and chlorhexidine were subjected to serial dilution to determine the lowest concentration at which bacterial growth was inhibited (MIC) and the lowest concentration that resulted in bacterial death (MBC). In comparison, chlorhexidine displayed significantly lower MIC and MBC values of 0.0003%, indicating its greater potency in inhibiting bacterial growth and causing bacterial death. When comparing these results with the existing literature, it is essential to consider variations in extraction methods, sample sources, and bacterial strains used in different studies. However, several studies have investigated the antimicrobial activity of
Allium species, including tassel onion, against various bacterial pathogens. For instance, research conducted by Lahiri D et al. reported the antimicrobial potential of Allium cepa (onion) extract against
Streptococcus mutans and
Streptococcus sanguinis, corroborating our findings (
19). Additionally, studies on the antimicrobial activity of chlorhexidine have consistently highlighted its effectiveness against a wide range of bacteria, including streptococci (
20,
21). Although the antimicrobial activity of the hydroalcoholic extract of
Allium atroviolaceum was less potent than chlorhexidine, it still exhibited significant inhibitory effects. This suggests that the extract could serve as a potential alternative or complementary treatment option, particularly in cases where synthetic antimicrobial agents may not be suitable or desired. However, a more detailed exploration of known bioactive compounds within
Allium atroviolaceum could be integrated to bolster the discussion. For instance,
Allium species contain organosulfur compounds, flavonoids, and polyphenols, each with antimicrobial properties. Investigating the interplay of these compounds with the bacterial strains tested could provide a more nuanced understanding of the extract's inhibitory potential. While acknowledging the limitations of the present study in identifying specific bioactive compounds, it is crucial to highlight the potential implications of such identification. Future research endeavors could focus on isolating and characterizing these compounds, unraveling the molecular mechanisms underpinning the extract's antimicrobial activity. This, in turn, may contribute to developing targeted and potent antimicrobial agents derived from
Allium atroviolaceum. In summary, augmenting the discussion with a more thorough exploration of the chemical constituents of
Allium atroviolaceum and their implications for antimicrobial activity would enrich the understanding of the extract's therapeutic potential.
5.1. Conclusion
In this investigation, we probed the antimicrobial prowess of the hydroalcoholic extract of Allium atroviolaceum alongside the widely used 0.2% chlorhexidine, targeting Streptococcus sanguinis, Streptococcus mutans, Streptococcus salivarius, and Streptococcus mitis through comprehensive well diffusion, MIC, and MBC assessments. Our findings distinctly showcase the inhibitory impact of Allium atroviolaceum on the tested streptococcal strains, manifesting as discernible growth inhibition zones in the well diffusion assay. Notably, the extract exerted its most potent inhibitory effect against Streptococcus salivarius, underscoring its strain-specific efficacy, albeit with comparatively lower effectiveness against Streptococcus mutans. Delving deeper through MIC and MBC analyses, the hydroalcoholic extract revealed MIC and MBC values of 3.12 mg/mL against Streptococcus sanguinis and 6.25 mg/mL against the remaining strains. While these values position Allium atroviolaceum as a viable antimicrobial contender, chlorhexidine emerged as a more potent adversary, displaying significantly lower MIC and MBC values of 0.0003%. This emphasizes chlorhexidine's robust capability in inhibiting bacterial growth and inducing bacterial death. In a broader context, our study adds substantial weight to the expanding body of evidence affirming the antimicrobial properties of Allium atroviolaceum. However, we recognize the imperative for continued exploration. Unraveling the specific bioactive compounds responsible for its antimicrobial activity is a priority. Future investigations should pivot toward isolating and characterizing these compounds, shedding light on their mechanisms of action, safety profiles, and plausible clinical applications.
Our work signals a critical juncture in understanding the antimicrobial potential of Allium atroviolaceum extract, illuminating promising avenues for the development of natural antimicrobial agents. This research transcends the laboratory, envisioning novel therapeutic alternatives for combatting bacterial infections. As we navigate the evolving landscape of antimicrobial research, Allium atroviolaceum emerges as a beacon of possibility, especially where synthetic antimicrobial agents may prove less suitable or preferred.